These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Studies towards the identification of a new generation of atypical antipsychotic agents. Garzya V, Forbes IT, Gribble AD, Hadley MS, Lightfoot AP, Payne AH, Smith AB, Douglas SE, Cooper DG, Stansfield IG, Meeson M, Dodds EE, Jones DN, Wood M, Reavill C, Scorer CA, Worby A, Riley G, Eddershaw P, Ioannou C, Donati D, Hagan JJ, Ratti EA. Bioorg Med Chem Lett; 2007 Jan 15; 17(2):400-5. PubMed ID: 17084080 [Abstract] [Full Text] [Related]
30. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding. Heidempergher F, Pillan A, Pinciroli V, Vaghi F, Arrigoni C, Bolis G, Caccia C, Dho L, McArthur R, Varasi M. J Med Chem; 1997 Oct 10; 40(21):3369-80. PubMed ID: 9341912 [Abstract] [Full Text] [Related]
33. Epiminocyclohepta[b]indole analogs as 5-HT6 antagonists. Henderson AJ, Guzzo PR, Ghosh A, Kaur J, Koo JM, Nacro K, Panduga S, Pathak R, Shimpukade B, Tan V, Xiang K, Wierschke JD, Isherwood ML. Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1494-8. PubMed ID: 22290076 [Abstract] [Full Text] [Related]
34. N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features. van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG. J Med Chem; 2011 Oct 27; 54(20):7030-54. PubMed ID: 21866910 [Abstract] [Full Text] [Related]
36. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity. Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S. J Med Chem; 2003 Feb 27; 46(5):702-15. PubMed ID: 12593651 [Abstract] [Full Text] [Related]
37. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists. Haydar SN, Yun H, Andrae PM, Mattes J, Zhang J, Kramer A, Smith DL, Huselton C, Graf R, Aschmies S, Schechter LE, Comery TA, Robichaud AJ. J Med Chem; 2010 Mar 25; 53(6):2521-7. PubMed ID: 20170099 [Abstract] [Full Text] [Related]